Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation Bridging

Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation Bridging

Publication: Pharmaceutics
Software: GastroPlus®

Basmisanil, is a lipophilic drug substance, exhibiting poor solubility and good permeability (BCS class 2). A validated physiologically based biopharmaceutics model (PBBM)...

Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats

Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats

Publication: Front Endocrinol
Software: ADMET Predictor®

Cholesterol is the precursor of all steroid hormones, and the entry of cholesterol into the mitochondria is the rate-limiting step of steroidogenesis.

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report

Publication: CPT Pharmacometrics Syst Pharmacol
Software: GastroPlus®

This workshop report summarizes the presentations and panel discussion related to the use of physiologically based pharmacokinetic (PBPK) modeling approaches for food...

Structure-activity relationship read-across and transcriptomics for branched carboxylic acids

Structure-activity relationship read-across and transcriptomics for branched carboxylic acids

Publication: Toxicol Sci
Software: GastroPlus®

The purpose of this study was to use chemical similarity evaluations, transcriptional profiling, in vitro toxicokinetic data, and physiologically based pharmacokinetic (PBPK)...

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools

Publication: Pharmaceutics

In the past decade, only a small number of papers have elaborated on the application of physiologically based pharmacokinetic (PBPK) modeling across different areas.

Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans

Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans

Publication: Cancers (Basel)

This study reports the first clinical evidence of significantly high secretion of matrine in a multi-component botanical (Antitumor B, ATB) into human saliva from the systemic...

Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches

Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches

Publication: Int J Mol Sciences
Software: GastroPlus®

Chemotherapy is the main treatment for most early-stage cancers; nevertheless, its efficacy is usually limited by drug resistance, toxicity, and tumor heterogeneity.

Non-specific binding of compounds in in vitro metabolism assays: a comparison of microsomal and hepatocyte binding in different species and an assessment of the accuracy of prediction models

Non-specific binding of compounds in in vitro metabolism assays: a comparison of microsomal and hepatocyte binding in different species and an assessment of the accuracy of prediction models

Publication: Xenobiotica
Division: PBPK

Non-specific binding in in vitro metabolism systems leads to an underestimation of the true intrinsic metabolic clearance of compounds being studied.

Model-Informed drug development of gastroretentive release systems for sildenafil citrate

Model-Informed drug development of gastroretentive release systems for sildenafil citrate

Publication: Eur J Pharm Biopharm
Software: GastroPlus®

Gastroretentive drug delivery systems (GRDDS) are modified-release dosage forms designed to prolong their residence time in the upper gastrointestinal tract...

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

Publication: CPT Pharmacometrics Syst Pharmacol

Model‐informed drug development (MIDD) approaches receive wide regulatory acceptance in the European Medicines Agency (EMA) to support new drug development.

Impact of chemical structure on the in vitro hydrolysis of fatty esters of 2-ethylhexanoic acid or 2-ethylhexanol and extrapolation to the in vivo situation

Impact of chemical structure on the in vitro hydrolysis of fatty esters of 2-ethylhexanoic acid or 2-ethylhexanol and extrapolation to the in vivo situation

Publication: Regul Toxicol Pharmacol
Software: GastroPlus®

Fatty esters of 2-ethylhexanoic acid (EHA) and 2-ethylhexanol (EH) are commonly used in cosmetics. Human liver and skin S9 and human plasma were used to determine the...

Mechanistic modeling of drug products applied to the skin: A workshop summary report

Mechanistic modeling of drug products applied to the skin: A workshop summary report

Publication: CPT Pharmacometrics Syst Pharmacol
Software: GastroPlus®

The development of a generic drug product involves demonstrating that there is no significant difference in the rate and extent to which the active ingredient becomes...

Development of Mefenamic Acid-Soluplus ® amorphous dispersions via hot melt extrusion and in silico prediction of oral absorption

Development of Mefenamic Acid-Soluplus ® amorphous dispersions via hot melt extrusion and in silico prediction of oral absorption

Publication: Acta Pharm Sci
Software: GastroPlus®

The objective of this study was to increase the solubility of Mefenamic Acid (MA), a BCS class II drug by formulating amorphous solid dispersions via Holt-Melt Extrusion.

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients

Publication: Pharmaceutics

Some years ago, excipients were considered inert substances irrelevant in the absorption process. However, years of study have demonstrated that this belief is not always true.